BioCentury
ARTICLE | Clinical News

Tacrolimus: Phase III started

January 5, 2009 8:00 AM UTC

LifeCycle began an international Phase III trial of once-daily LCP-Tacro vs. twice-daily Prograf in 300 stable kidney transplant patients. Astellas Pharma Inc. (Tokyo:4503, Tokyo, Japan) markets Prog...